Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rang in aandelen #2093
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aandeelprijs
$141.47
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$9.81B
Verandering (1 dag)
0.26%
Verandering (1 jaar)
-56.72%
Land
US
Handel Insulet Corp. (PODD)

Categorie

Healthcare
Aandelsplitsingen voor Insulet Corp. (PODD)
Het aandeel Insulet Corp. (symbool: PODD) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 20, 2026.
Eén aandeel PODD dat vóór Oct 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen PODD.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE